Cutera Stock

Cutera ROE

Delisted

The Return on Equity (ROE) of Cutera (CUTRQ) as of Sep 9, 2026 is 94.76 %. In the previous year, Return on Equity (ROE) was 541.45 % — a change of -82.50% (lower).

ROE

94.76 %

YoY

-82.50%

Last updated:

In 2026, Cutera's return on equity (ROE) was 94.76 %, a -82.50% increase from the 541.45 % ROE in the previous year.

The Cutera ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2016
4.26 USD
Jan 1, 2017
46.22 USD
Jan 1, 2018
-66.38 USD
Jan 1, 2019
-26.80 USD
Jan 1, 2020
-42.00 USD
Jan 1, 2021
3.71 USD
Jan 1, 2022
541.45 USD
Jan 1, 2023
94.76 USD
The Cutera ROE history
YEARROEYoY
94.76 %-82.50%
541.45 %+14,493.30%
3.71 %-108.83%
-42.00 %+56.74%
-26.80 %-59.63%
-66.38 %-243.60%
46.22 %+984.51%
4.26 %-148.44%
-8.80 %-33.17%
-13.17 %
Access this data via the Eulerpool API

Cutera Stock analysis

What does Cutera do? Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. The company was founded in California in 1998 and has since had a successful history in the beauty and medical care industry. Cutera's business model consists of developing and selling innovative laser devices used in the cosmetics and medical industries. The company's goal is to offer its customers (doctors, beauty clinics, etc.) the latest and most effective laser technologies to meet the needs and expectations of their patients. In recent years, Cutera has focused on several areas to offer its customers a wider range of products. These include skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment, and tattoo removal. The company has over 20 different products in its portfolio, all tailored to the needs of different patient groups. In the field of skin rejuvenation, Cutera offers variants such as Laser Genesis Plus, Genesis V, Excel HR, and other lasers to treat wrinkles, fine lines, pigment irregularities, and texture problems. Body contouring is made possible through devices such as Sculpture and TruSculpt 3D. Hair removal is supported by the ProWave, CoolGlide, and XEO system. Treatment of vascular and pigmented lesions is done through devices such as Excel HR, LimeLight, and the XEO system. For scar treatment and tattoo removal, lasers such as Enlighten and Genesis V are used. Cutera has gained an excellent reputation in the industry through its innovative products and sustainable business philosophy. The company aims to meet the needs and expectations of its customers by providing innovative technologies, high-quality products, and outstanding customer service. Cutera continually invests in research and development to ensure that it can always offer its customers the latest and best laser devices. Additionally, the company places great importance on the safety of its products and has specialized in training and education for its customers and users. Recently, Cutera Inc. has also made strides in telemedicine to better support its customers. This allows doctors and users to access support anytime and anywhere, for example, for training and technical support. In summary, Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. Its wide range of products tailored to the different needs and expectations of patients has earned it an excellent reputation in the industry. Cutera continuously invests in research and development, offers outstanding customer service, and places great importance on the safety of its products. In the future, the company will continue to develop innovative technologies, revolutionizing beauty and medical care. Cutera is one of the most popular companies on Eulerpool.

ROE Details

Decoding Cutera's Return on Equity (ROE)

Cutera's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Cutera's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Cutera's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Cutera’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Cutera stock

Return on Equity (ROE) of Cutera is 94.76 % in 2026.

Return on Equity (ROE) of Cutera changed from 541.45 % to 94.76 %, representing a -82.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Cutera since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Cutera with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Cutera

All Key Metrics — Cutera